1. Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues
   Cornelia Tolg et al, 2014, BioMed Research International CrossRef
2. Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells
   XIN JIAN FANG et al, 2014 CrossRef
3. Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanism
   LI ZHANG et al, 2014 CrossRef
4. A novel role of low molecular weight hyaluronan in breast cancer metastasis
   Man Wu et al, 2015, The FASEB Journal CrossRef
5. Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans
   Spyros S. Skandalis et al, 2014, Matrix Biology CrossRef
6. Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
   Anastasia G. Tavianatou et al, 2019, FEBS J CrossRef
7. Hyaluronan: Towards novel anti-cancer therapeutics
   Michał S. Karbownik et al, 2013, Pharmacological Reports CrossRef
8. Sugars in the microenvironment: the sticky problem of HA turnover in tumors
   Anja Schmaus et al, 2014, Cancer Metastasis Rev CrossRef
9. null
   Di Jia et al, 2015 CrossRef
10. Metalloproteinases and their roles in human cancer
    Roopali Roy et al, 2019, Anat Rec CrossRef
11. Hyaluronan in cancer – from the naked mole rat to nanoparticle therapy
    Kenneth S. Rankin et al, 2016, Soft Matter CrossRef
12. null
    , 2016 CrossRef
13. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
    Evgenia Karousou et al, 2017, Matrix Biology CrossRef
14. Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP
    Sana Waheed et al, 2017, Oncotarget CrossRef
15. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells
    Zhe Wang et al, 2016, Oncotarget CrossRef
16. The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data
    Yu Hu et al, 2020, Bioengineered CrossRef
17. Hyaluronic acid predicts poor prognosis in breast cancer patients
    Weiping Wu et al, 2020 CrossRef
18. Proteolytic Processing of CD44 and Its Implications in Cancer
    Priscila Anhel Medrano-González et al, 2021, Stem Cells International CrossRef
19. Label-free Electrogenerated Chemiluminescence Biosensor for Quantization of CD44 on basis of its Heterodimerization with Matrix Metalloproteinase-14
    Yuhong Duan et al, 2022, Microchemical Journal CrossRef
20. Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment
    Ana M. Carvalho et al, 2022, Adv Healthcare Materials CrossRef
21. Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review
    Monika Michalczyk et al, 2022, IJMS CrossRef
22. Dysregulation of ADAM10 shedding activity in naked mole‐rat fibroblasts is due to deficient phosphatidylserine externalization
    Paulina Urriola‐Muñoz et al, 2023, Journal Cellular Physiology CrossRef
23. Label-Free Electrogenerated Chemiluminescence Biosensor for Quantization of CD44 on Basis of its Heterodimerization with Matrix Metalloproteinase-14
    Yuhong Duan et al, 2022, SSRN Journal CrossRef
24. Cluster of differentiation 44 and matrix metalloproteinase 2 markers: A prospective study and insight to their role in bladder cancer
    Manoj Yadav et al, 2023, Indian J Health Sci Biomed Res CrossRef
25. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study
    Yu Lei et al, 2023 CrossRef